Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
Gastric cancer with peritoneal carcinomatosis is a disease with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) can improve prognosis, although in most cases this should still be considered as a palliative treatment. Therefore, morbid...
Main Authors: | Bielen, Rob, Verswijvel, Geert, Van der Speeten, Kurt |
---|---|
Format: | Online |
Language: | English |
Published: |
S. Karger AG
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573814/ |
Similar Items
-
Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
by: Campanati, Renato Gomes, et al.
Published: (2014) -
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
by: Murughan, Kavita, et al.
Published: (2014) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Piso, Pompiliu, et al.
Published: (2004) -
Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Macrì, Antonio, et al.
Published: (2015) -
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Girshally, Ramy, et al.
Published: (2016)